Filtered By:
Condition: Spinal Cord Injury
Management: Marketing

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 6 results found since Jan 2013.

Stroke Rehab Technology Aims To Speed Healing
Watching someone who has suffered a stroke try to perform everyday actions such as walking down the sidewalk or even bringing a cup to their lips can serve as a sobering reminder of how fragile full and robust health is, and also serves as an inspiration for those dedicated to improving the lives of those patients. Steven Plymale, recently named CEO of Toronto-based MyndTec, said his reaction to watching videos of patients using the company's MyndMove functional electrical stimulation (FES) rehabilitation system was one of the reasons he joined MyndTec. "They are very compelling," Plymale said of the demonstration videos,Â...
Source: MDDI - November 22, 2017 Category: Medical Devices Authors: Greg Goth Tags: Electronics Source Type: news

Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
First robotic exoskeleton cleared for use with stroke and spinal cord injury levels to C7 RICHMOND, Calif., April 04, 2016 -- (Healthcare Sales & Marketing Network) -- Ekso Bionics Holdings, Inc. (EKSO), a robotic exoskeleton company, today announced th... Devices, Neurology, FDAEkso Bionics, robotic exoskeleton, Ekso GT, stroke
Source: HSMN NewsFeed - April 4, 2016 Category: Pharmaceuticals Source Type: news

Learning to Walk Again
When someone suffers a stroke, he or she often loses some mobility, and some 60 percent of survivors are left with lower-limb deficits. “They usually have one leg that's more impaired than the other leg, and then they undergo rehabilitation and physical therapy. And often they don't fully recover,” said Conor Walsh, professor of engineering and applied sciences at the John A. Paulson Harvard School of Engineering and Applied Sciences and a core faculty member at the Wyss Institute for Biologically Inspired Engineering, in an interview with MD+DI. But a new device called ReSto...
Source: MDDI - April 17, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Design Source Type: news

FDA OKs expansion of InVivo Therapeutics spinal scaffold study
InVivo Therapeutics (NSDQ:NVIV) said today that the FDA cleared an expansion of its Inspire study of its neuro-spinal scaffold, now set to enroll up to 20 patients, and announced the 9th and 10th implantation in the trial, though the 10th patient died of an unrelated stroke. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. The federal watchdog cleared the company to expand the trial for up to 20 evaluable patients. The decision came based off the review of 6-month safety data from the trial, InViv...
Source: Mass Device - July 12, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Spinal InVivo Therapeutics Corp. Source Type: news

Umbilical Cord Blood Mononuclear Cells for Ex-Vivo Gene Therapy
This study was supported by the grant of Russian Science Foundation No 16-15-00010. Kazan Federal University was supported by the Russian Government Program of Competitive Growth.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - November 21, 2018 Category: Hematology Authors: Bashirov, F. V., Salafutdinov, I. I., Sokolov, M. E., Izmailov, A. A., Markosyan, V. A., Fadeev, F. O., Rizvanov, A., Islamov, R. I. Tags: 801. Gene Therapy and Transfer Source Type: research

Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
AUSTIN, Texas, Aug. 28, 2019 -- (Healthcare Sales & Marketing Network) -- Harmonic Bionics, Inc. announced today that Christopher Prentice has been appointed Chief Executive Officer and member of the Harmonic Bionics Board of Directors effective immediate... Devices, Personnel Harmonic Bionics, stroke, spinal cord injury, neurorehabilitation
Source: HSMN NewsFeed - August 28, 2019 Category: Pharmaceuticals Source Type: news